Expression of the histone methyltransferase EZH2 in colorectal cancer

被引:0
|
作者
Carvalho, S. Dias [1 ]
Monteiro-Reis, S. [1 ]
Vieira-Coimbra, M. [1 ]
Pires-Luis, A. [1 ]
Tavares, A. [1 ]
Santos, L. L. [1 ]
Raimundo, A. [1 ]
Jeronimo, C. [1 ]
Henrique, R. [1 ]
机构
[1] Portuguese Oncol Inst, Oporto, Portugal
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OFP-01-013
引用
下载
收藏
页码:S4 / S4
页数:1
相关论文
共 50 条
  • [21] Epigenetic control of skeletal development by the histone methyltransferase EZH2
    Dudakovic, Amel
    Xu, Fuhua
    Camilleri, Emily
    McGee-Lawrence, Meghan
    Lewallen, Eric
    Riester, Scott
    Hawse, John R.
    Stein, Gary
    Montecino, Martin
    Westendorf, Jennifer
    Van Wijnen, Andre
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S40 - S40
  • [22] The histone methyltransferase Ezh2 restrains macrophage inflammatory responses
    Kitchen, Gareth B.
    Hopwood, Thomas
    Ramamoorthy, Thanuja Gali
    Downton, Polly
    Begley, Nicola
    Hussell, Tracy
    Dockrell, David H.
    Gibbs, Julie E.
    Ray, David W.
    Loudon, Andrew S., I
    FASEB JOURNAL, 2021, 35 (10):
  • [23] Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders
    Ernst, T.
    Chase, A.
    Score, J.
    Hidalgo-Curtis, C.
    Bryant, C.
    Jones, A.
    Waghorn, K.
    Zoi, K.
    Ross, F.
    Reiter, A.
    Hochhaus, A.
    Drexler, H.
    Duncombe, A.
    Cervantes, F.
    Oscier, D.
    Boultwood, J.
    Grand, F.
    Cross, N.
    ONKOLOGIE, 2010, 33 : 118 - 118
  • [24] Triptolide Inhibits Histone Methyltransferase EZH2 and Modulates the Expression of Its Target Genes in Prostate Cancer Cells
    Tamgue, Ousman
    Chai, Cheng-Sen
    Hao, Lin
    Zambe, John-Clotaire Daguia
    Huang, Wei-Wei
    Zhang, Bin
    Lei, Ming
    Wei, Yan-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (10) : 5663 - 5669
  • [25] The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
    Miele, Evelina
    Valente, Sergio
    Alfano, Vincenzo
    Silvano, Marianna
    Mellini, Paolo
    Borovika, Diana
    Marrocco, Biagina
    Po, Agnese
    Besharat, Zein Mersini
    Catanzaro, Giuseppina
    Battaglia, Giuseppe
    Abballe, Luana
    Zwergel, Clemens
    Stazi, Giulia
    Milite, Ciro
    Castellano, Sabrina
    Tafani, Marco
    Trapencieris, Peteris
    Mai, Antonello
    Ferretti, Elisabetta
    ONCOTARGET, 2017, 8 (40) : 68557 - 68570
  • [26] Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
    H Taniguchi
    F V Jacinto
    A Villanueva
    A F Fernandez
    H Yamamoto
    F J Carmona
    S Puertas
    V E Marquez
    Y Shinomura
    K Imai
    M Esteller
    Oncogene, 2012, 31 : 1988 - 1994
  • [27] Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
    Taniguchi, H.
    Jacinto, F. V.
    Villanueva, A.
    Fernandez, A. F.
    Yamamoto, H.
    Carmona, F. J.
    Puertas, S.
    Marquez, V. E.
    Shinomura, Y.
    Imai, K.
    Esteller, M.
    ONCOGENE, 2012, 31 (15) : 1988 - 1994
  • [28] Expression of EZH2 is associated with poor outcome in colorectal cancer
    Chen, Zhuanpeng
    Yang, Ping
    Li, Wanglin
    He, Feng
    Wei, Jianchang
    Zhang, Tong
    Zhong, Junbin
    Chen, Huacui
    Cao, Jie
    ONCOLOGY LETTERS, 2018, 15 (03) : 2953 - 2961
  • [29] Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
    Kuang, Yan
    Lu, Fangfang
    Guo, Jianfeng
    Xu, Hong
    Wang, Qi
    Xu, Chaohuan
    Zeng, Longjia
    Yi, Suyi
    ONCOTARGETS AND THERAPY, 2017, 10 : 3131 - 3144
  • [30] Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease
    A. Herrera-Merchan
    L. Arranz
    J.M. Ligos
    A. de Molina
    O. Dominguez
    S. Gonzalez
    Nature Communications, 3